The Pharmaceutical Benefits Advisory Committee (PBAC) considered an application for the inclusion of the above-mentioned item on the Emergency Drug (Doctor's Bag) Supplies List at its March 1995 meeting.
The application was rejected since the only known adrenaline 1:10 000 injection product is supplied in 10 mL ampoules in packs of 50, whereas a single 1 mL ampoule (or at least no more than 5) would be most suitable for pharmaceutical benefit listing.
Further, the PBAC felt that by using a tuberculin syringe, an appropriate volume could be extracted from the currently listed adrenaline 1:1000 product. In addition, the presence of two strengths of adrenaline in a doctor's bag could lead to confusion in an emergency.